Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07414589 · ClinicalTrials.gov registry record · NA
Brief Alcohol Treatment for Women Veterans in Primary Care
A NA study, sponsored by Syracuse VA Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT07414589: Clinical Trial NA study, sponsored by Syracuse VA Medical Center.
NCT07414589 is a NA study that has not yet begun recruiting, run by Syracuse VA Medical Center. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07414589, a NA study, has not yet begun recruiting, sponsored by Syracuse VA Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The goal of this study is to develop and test a brief behavioral treatment for women Veterans with alcohol use in primary care. The study involves a development phase, an open trial phase, and a pilot randomized controlled trial. The main questions it aims to answer are: * Is the treatment feasible and acceptable to women Veteran primary care patients? * Can the treatment help reduce alcohol use, alcohol-related problems, and improve quality of life? Researchers will compare the new treatment to usual treatment that primary care patients would normally receive. Participants will be asked to participate in either the new behavioral treatment or usual primary care treatment and attend 3 appointments to answer questions about their alcohol use, quality of life, other mental health symptoms, and what they thought of their behavioral treatment.
Primary Outcome
Quality of life will be assessed by the abbreviated World Health Organization Quality of Life Assessment (WHOQOL-BREF), a 26-item self-report measure of QoL in the past 2 weeks in 4 areas (social, physical, psychological, and environment) on a 1-5 scale.
Interventions
- BEHAVIORAL Brief, Integrated Intervention for Women Veterans with Unhealthy Alcohol Use in Primary Care
- BEHAVIORAL Primary care usual care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2026-10 |
| Est. Completion | 2030-08 |
| Phase | NA |
What is known before NCT07414589 opens enrollment
NCT07414589 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Brief, Integrated Intervention for Women Veterans with Unhealthy Alcohol Use in Primary Care is the first listed.
NCT07414589 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07414589 about?
NCT07414589 is a clinical study titled "Brief Alcohol Treatment for Women Veterans in Primary Care". The goal of this study is to develop and test a brief behavioral treatment for women Veterans with alcohol use in primary care. The study involves a development phase, an open trial phase, and a pilot randomized controlled trial. The main questions it aims to answer are: * Is the treatment feasible...
What is the current status of trial NCT07414589?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2026-10. Estimated completion is 2030-08.
What interventions are being tested in trial NCT07414589?
The interventions under investigation include: Brief, Integrated Intervention for Women Veterans with Unhealthy Alcohol Use in Primary Care (BEHAVIORAL), Primary care usual care (BEHAVIORAL).
Who is sponsoring clinical trial NCT07414589?
This trial is sponsored by Syracuse VA Medical Center, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07414589's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia